Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada-Reference-Cited by-同舟云学术

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

Published:2023-07 Issue:7 Volume:5 Page:100675
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Ha Jeffrey T.^ORCID,Scaria Anish,Andrade Jason,Badve Sunil V.,Birks Peter,Bota Sarah E.,Campain Anna,Djurdjev Ognjenka,Garg Amit X.,Harel Ziv,Hemmelgarn Brenda,Hockham Carinna,James Matthew T.,Jardine Meg J.,Lam Dickson,Levin Adeera,McArthur Eric,Ravani Pietro,Shao Selena,Sood Manish M.,Tan Zhi,Tangri Navdeep,Whitlock Reid,Gallagher Martin,Jun Min

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference31 articles.

1. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study;Go;Circulation,2009

2. Incident atrial fibrillation and the risk of congestive heart failure, myocardial infarction, end-stage kidney disease, and mortality among patients with a decreased estimated GFR;Massicotte-Azarniouch;Am J Kidney Dis,2018

3. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis;Masson;Nephrol Dial Transplant,2015

4. Incident atrial fibrillation and risk of death in adults with chronic kidney disease;Bansal;J Am Heart Assoc,2014

5. Risks and benefits of direct oral anticoagulants across the spectrum of GFR among incident and prevalent patients with atrial fibrillation;Shin;Clin J Am Soc Nephrol,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease;Journal of the American Heart Association;2024-08-20

2. Innovations in pharmacovigilance studies of medicines in older people;British Journal of Clinical Pharmacology;2024-03-26

3. Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review;Seminars in Nephrology;2024-03

4. Anticoagulation for Atrial Fibrillation in Advanced CKD: Can Observational Studies Provide the Answer?;American Journal of Kidney Diseases;2024-03

5. Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study;American Journal of Kidney Diseases;2023-10